| 【Company Research】Xtep (1368 HK) - 2Q25 was weak but guidance remained intact |
| 【Company Research】Innolight (300308 CH) - 2Q earnings reinforce AI infrastructure spend momentum |
| 【Company Research】Tongcheng Travel (780 HK) - 2Q25 preview: expecting inline results |
| 【Company Research】Shengyi Tech (600183 CH) - Strong 1H25 results underscore AI-driven strength |
| 【行业研究】软件 & IT服务 - 财税数字化软件：合规效率双赢，云端渗透加速 |
| 【Company Research】Anta Sports (2020 HK) - Anta brand’s miss offset by other brands’ beat |
| 【Sector Research】Technology - Implications of resumption of H20/MI308 sales in China; Positive for AI server/component supply chain |
| 【Company Research】Li Ning (2331 HK) - 2Q25 roughly inline and transition in progress |
| 【公司研究】巨子生物 (2367 HK) - 销售复苏在望，底部布局正当时 |
| 【Company Research】Bilibili (BILI US) - 2025 Investor Day: improving monetization to support quality earnings growth |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
